88. Chronic thromboembolic pulmonary hypertension Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 187 / Drugs : 144 - (DrugBank : 24) / Drug target genes : 18 - Drug target pathways : 82
Chronic thromboembolic pulmonary hypertension and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 88 | Chronic thromboembolic pulmonary hypertension | - |
| 86 | Pulmonary arterial hypertension | 11.188 |
| 51 | Scleroderma | 7.897 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 6.324 |
| 85 | Idiopathic interstitial pneumonia | 5.172 |
| 84 | Sarcoidosis | 4.045 |
| 46 | Malignant rheumatoid arthritis | 3.891 |
| 6 | Parkinson disease | 2.872 |
| 91 | Budd-Chiari syndrome | 2.423 |
| 87 | Pulmonary veno-occlusive disease | 2.423 |
| 8 | Huntington disease | 2.106 |
| 96 | Crohn disease | 2.015 |
| 47 | Buerger disease | 1.846 |
| 89 | Lymphangioleiomyomatosis | 1.641 |
| 225 | Congenital nephrogenic diabetes insipidus | 1.600 |
| 210 | Single Ventricle | 1.577 |
| 162 | Pemphigoid | 1.566 |
| 66 | IgA nephropathy | 1.547 |
| 58 | Hypertrophic cardiomyopathy | 1.462 |
| 34 | Neurofibromatosis | 1.358 |
| 299 | Cystic fibrosis | 1.346 |
| 49 | Systemic lupus erythematosus | 1.328 |
| 97 | Ulcerative colitis | 1.308 |
| 35 | Pemphigus | 1.007 |